BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ananthakrishnan A, Gogineni V, Saeian K. Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol. 2006;23:47-63. [PMID: 21326720 DOI: 10.1055/s-2006-939841] [Cited by in Crossref: 98] [Cited by in F6Publishing: 81] [Article Influence: 8.9] [Reference Citation Analysis]
Number Citing Articles
1 März K, Hafezi M, Weller T, Saffari A, Nolden M, Fard N, Majlesara A, Zelzer S, Maleshkova M, Volovyk M, Gharabaghi N, Wagner M, Emami G, Engelhardt S, Fetzer A, Kenngott H, Rezai N, Rettinger A, Studer R, Mehrabi A, Maier-Hein L. Toward knowledge-based liver surgery: holistic information processing for surgical decision support. Int J Comput Assist Radiol Surg 2015;10:749-59. [PMID: 25847671 DOI: 10.1007/s11548-015-1187-0] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
2 Lu NT, Liu NM, Patel D, Vu JQ, Liu L, Kim CY, Cho P, Khachatoorian R, Patel N, Magyar CE, Ganapathy E, Arumugaswami V, Dasgupta A, French SW. Oncoprotein Stathmin Modulates Sensitivity to Apoptosis in Hepatocellular Carcinoma Cells During Hepatitis C Viral Replication. J Cell Death 2018;11:1179066018785141. [PMID: 30034249 DOI: 10.1177/1179066018785141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Bhat M, Pasini E, Pastrello C, Angeli M, Baciu C, Abovsky M, Coffee A, Adeyi O, Kotlyar M, Jurisica I. Estrogen Receptor 1 Inhibition of Wnt/β-Catenin Signaling Contributes to Sex Differences in Hepatocarcinogenesis. Front Oncol 2021;11:777834. [PMID: 34881186 DOI: 10.3389/fonc.2021.777834] [Reference Citation Analysis]
4 Ichikawa S, Motosugi U, Suzuki T, Shimizu T, Onishi H. Imaging features of hepatic inflammatory pseudotumor: distinction from colorectal liver metastasis using gadoxetate disodium-enhanced magnetic resonance imaging. Abdom Radiol (NY) 2020;45:2400-8. [PMID: 32468212 DOI: 10.1007/s00261-020-02575-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Ronen S, Prieto VG, Aung PP. Epithelioid angiomyolipoma mimicking metastatic melanoma in a liver tumor. J Cutan Pathol. 2020;47:824-828. [PMID: 32274822 DOI: 10.1111/cup.13705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Noda C, Williams GA, Foltz G, Kim H, Sanford DE, Hammill CW, Fields RC. The safety of hepatectomy after transarterial radioembolization: Single institution experience and review of the literature. J Surg Oncol 2020;122:1114-21. [PMID: 32662066 DOI: 10.1002/jso.26115] [Reference Citation Analysis]
7 Vogel A, Gupta S, Zeile M, von Haken R, Brüning R, Lotz G, Vahrmeijer A, Vogl T, Wacker F. Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review. Adv Ther 2017;33:2122-38. [PMID: 27798773 DOI: 10.1007/s12325-016-0424-4] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
8 Dutta D, Tatineni T, Yarlagadda S, Gupte A, Reddy SK, Madhavan R, Nair H, Sasidharan A, Kannan R, Pottayil SG, Holla R, Sudhindran S. Hepatocellular carcinoma patients with portal vein thrombosis treated with robotic radiosurgery: Interim results of a prospective study. Indian J Gastroenterol 2021;40:389-401. [PMID: 34694581 DOI: 10.1007/s12664-021-01172-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Timperi E, Barnaba V. Viral Hepatitides, Inflammation and Tumour Microenvironment. Adv Exp Med Biol 2020;1263:25-43. [PMID: 32588321 DOI: 10.1007/978-3-030-44518-8_3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kohler BA, Sherman RL, Howlader N, Jemal A, Ryerson AB, Henry KA, Boscoe FP, Cronin KA, Lake A, Noone AM, Henley SJ, Eheman CR, Anderson RN, Penberthy L. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State. J Natl Cancer Inst 2015;107:djv048. [PMID: 25825511 DOI: 10.1093/jnci/djv048] [Cited by in Crossref: 435] [Cited by in F6Publishing: 406] [Article Influence: 62.1] [Reference Citation Analysis]
11 Arzumanian VA, Kiseleva OI, Poverennaya EV. The Curious Case of the HepG2 Cell Line: 40 Years of Expertise. Int J Mol Sci 2021;22:13135. [PMID: 34884942 DOI: 10.3390/ijms222313135] [Reference Citation Analysis]
12 Oyama A, Shiraha H, Uchida D, Iwamuro M, Kato H, Takaki A, Ikeda F, Onishi H, Yasunaka T, Takeuchi Y, Wada N, Iwasaki Y, Sakata M, Okada H, Kumon H. A Phase I/Ib trial of Ad-REIC in liver cancer: study protocol. Future Oncology 2019;15:3547-54. [DOI: 10.2217/fon-2019-0115] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
13 Shih EJ, Chau IY, Yeh YC, Chau GY. Synchronous hepatocellular carcinoma and lymphoepithelioma-like carcinoma arising from 2 different sites of the liver: A case report. Medicine (Baltimore) 2018;97:e12548. [PMID: 30290612 DOI: 10.1097/MD.0000000000012548] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Ashtari S, Pourhoseingholi MA, Sharifian A, Zali MR. Hepatocellular carcinoma in Asia: Prevention strategy and planning. World J Hepatol 2015; 7(12): 1708-1717 [PMID: 26140091 DOI: 10.4254/wjh.v7.i12.1708] [Cited by in Crossref: 54] [Cited by in F6Publishing: 45] [Article Influence: 7.7] [Reference Citation Analysis]
15 Mao ZY, Guo XC, Su D, Wang LJ, Zhang TT, Bai L. Prognostic Factors of Cholangiocarcinoma After Surgical Resection: A Retrospective Study of 293 Patients. Med Sci Monit 2015;21:2375-81. [PMID: 26269932 DOI: 10.12659/MSM.893586] [Cited by in Crossref: 11] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
16 Pope ED 3rd, Kimbrough EO, Vemireddy LP, Surapaneni PK, Copland JA 3rd, Mody K. Aberrant lipid metabolism as a therapeutic target in liver cancer. Expert Opin Ther Targets 2019;23:473-83. [PMID: 31076001 DOI: 10.1080/14728222.2019.1615883] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
17 Fraga J, Caetano Oliveira R, Terracciano L, Silva MR, Cipriano MA. Hepatic Myxoid Leiomyoma: A Very Rare Tumor. GE Port J Gastroenterol 2020;27:352-5. [PMID: 32999907 DOI: 10.1159/000504762] [Reference Citation Analysis]
18 Schau GF, Burlingame EA, Thibault G, Anekpuritanang T, Wang Y, Gray JW, Corless C, Chang YH. Predicting primary site of secondary liver cancer with a neural estimator of metastatic origin. J Med Imaging (Bellingham) 2020;7:012706. [PMID: 34541020 DOI: 10.1117/1.JMI.7.1.012706] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Castro-Gil MP, Torres-Mena JE, Salgado RM, Muñoz-Montero SA, Martínez-Garcés JM, López-Torres CD, Mendoza-Vargas A, Gabiño-López NB, Villa-Treviño S, Del Pozo-Yauner L, Arellanes-Robledo J, Krötzsch E, Pérez-Carreón JI. The transcriptome of early GGT/KRT19-positive hepatocellular carcinoma reveals a downregulated gene expression profile associated with fatty acid metabolism. Genomics 2021;114:72-83. [PMID: 34861383 DOI: 10.1016/j.ygeno.2021.11.035] [Reference Citation Analysis]
20 Ashokachakkaravarthy K, Pottakkat B. Mitotic quiescence in hepatic cancer stem cells: An incognito mode. Oncol Rev 2020;14:452. [PMID: 32153726 DOI: 10.4081/oncol.2020.452] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Wang Z, Li X, Chen J, Shi H, Pan J, Zhang X, Jin Z. Safety and effectiveness of repeat arterial closure using the StarClose vascular closure device in patients with hepatic malignancy. Clin Radiol 2013;68:e498-501. [PMID: 23706825 DOI: 10.1016/j.crad.2013.04.001] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
22 Zagorulya M, Duong E, Spranger S. Impact of anatomic site on antigen-presenting cells in cancer. J Immunother Cancer 2020;8:e001204. [PMID: 33020244 DOI: 10.1136/jitc-2020-001204] [Reference Citation Analysis]
23 Zarour LR, Billingsley KG, Walker BS, Enestvedt CK, Orloff SL, Maynard E, Mayo SC. Hepatic resection of solitary HCC in the elderly: A unique disease in a growing population. Am J Surg 2019;217:899-905. [PMID: 30819401 DOI: 10.1016/j.amjsurg.2019.01.030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
24 VoPham T, Brooks MM, Yuan JM, Talbott EO, Ruddell D, Hart JE, Chang CC, Weissfeld JL. Pesticide exposure and hepatocellular carcinoma risk: A case-control study using a geographic information system (GIS) to link SEER-Medicare and California pesticide data. Environ Res 2015;143:68-82. [PMID: 26451881 DOI: 10.1016/j.envres.2015.09.027] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 5.4] [Reference Citation Analysis]
25 Kukla DA, Khetani SR. Bioengineered Liver Models for Investigating Disease Pathogenesis and Regenerative Medicine. Semin Liver Dis 2021;41:368-92. [PMID: 34139785 DOI: 10.1055/s-0041-1731016] [Reference Citation Analysis]
26 Ho JL, Konda A, Rahman J, Harris E, Korn R, Sabir A, Bawany B, Gulati R, Harris GJ, Boswell WD, Fong Y, Rahmanuddin S. Comparative analysis of three-dimensional volume rendering and maximum intensity projection for preoperative planning in liver cancer. Eur J Radiol Open 2020;7:100259. [PMID: 32944595 DOI: 10.1016/j.ejro.2020.100259] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
27 Ng ZL, Siew J, Li J, Ji G, Huang M, Liao X, Yu S, Chew Y, Png CW, Zhang Y, Wen S, Yang H, Zhou Y, Long YC, Jiang ZH, Wu Q. PATZ1 (MAZR) Co-occupies Genomic Sites With p53 and Inhibits Liver Cancer Cell Proliferation via Regulating p27. Front Cell Dev Biol 2021;9:586150. [PMID: 33598459 DOI: 10.3389/fcell.2021.586150] [Reference Citation Analysis]
28 Wojcieszynski AP, Rosenberg SA, Brower JV, Hullett CR, Geurts MW, Labby ZE, Hill PM, Bayliss RA, Paliwal B, Bayouth JE, Harari PM, Bassetti MF. Gadoxetate for direct tumor therapy and tracking with real-time MRI-guided stereotactic body radiation therapy of the liver. Radiotherapy and Oncology 2016;118:416-8. [DOI: 10.1016/j.radonc.2015.10.024] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
29 Klein J, Dawson LA, Jiang H, Kim J, Dinniwell R, Brierley J, Wong R, Lockwood G, Ringash J. Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys. 2015;93:16-25. [PMID: 26279020 DOI: 10.1016/j.ijrobp.2015.04.016] [Cited by in Crossref: 42] [Cited by in F6Publishing: 35] [Article Influence: 6.0] [Reference Citation Analysis]
30 Bayik D, Lauko AJ, Roversi GA, Serbinowski E, Acevedo-Moreno LA, Lanigan C, Orujov M, Lo A, Alban TJ, Kim A, Silver DJ, Nagy LE, Brown JM, Allende DS, Aucejo FN, Lathia JD. Hepatobiliary malignancies have distinct peripheral myeloid-derived suppressor cell signatures and tumor myeloid cell profiles.Sci Rep. 2020;10:18848. [PMID: 33139767 DOI: 10.1038/s41598-020-75881-1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
31 Lee YH, Lee JI. Metastatic carcinoma of the oral region: An analysis of 21 cases. Med Oral Patol Oral Cir Bucal 2017;22:e359-65. [PMID: 28390123 DOI: 10.4317/medoral.21566] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
32 Moya IM, Halder G. Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine. Nat Rev Mol Cell Biol. 2019;20:211-226. [PMID: 30546055 DOI: 10.1038/s41580-018-0086-y] [Cited by in Crossref: 182] [Cited by in F6Publishing: 176] [Article Influence: 60.7] [Reference Citation Analysis]
33 Zhai B, Jin X, Wang R, Fang T, Qu J, Wang Y, Liu M, Xu L. Applying negative pressure wound therapy in associating liver partition and portal vein ligation for staged hepatectomy: A case report. Exp Ther Med 2017;14:642-6. [PMID: 28672979 DOI: 10.3892/etm.2017.4566] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
34 Yammine K, Kamar F, Nasser J, Tayar C, Ghosn M, Chehade F, Daher J, Nicolas G. Single-Institution Experience with Selective Internal Radiation Therapy (SIRT) for the Treatment of Primary and Secondary Hepatic Tumors. Cureus. [DOI: 10.7759/cureus.7628] [Reference Citation Analysis]
35 Eo JS, Paeng JC, Lee DS. Nuclear imaging for functional evaluation and theragnosis in liver malignancy and transplantation. World J Gastroenterol 2014; 20(18): 5375-5388 [PMID: 24833867 DOI: 10.3748/wjg.v20.i18.5375] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
36 Neshat H, Cool DW, Barker K, Gardi L, Kakani N, Fenster A. A 3D ultrasound scanning system for image guided liver interventions: A 3D ultrasound system for image-guided liver interventions. Med Phys 2013;40:112903. [DOI: 10.1118/1.4824326] [Cited by in Crossref: 33] [Cited by in F6Publishing: 18] [Article Influence: 3.7] [Reference Citation Analysis]
37 Tameez Ud Din A, Tameez-Ud-Din A, Chaudhary FMD, Chaudhary NA, Siddiqui KH. Irreversible Electroporation For Liver Tumors: A Review Of Literature. Cureus 2019;11:e4994. [PMID: 31497425 DOI: 10.7759/cureus.4994] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
38 Laursen L. A preventable cancer. Nature. 2014;516:S2-S3. [PMID: 25470197 DOI: 10.1038/516s2a] [Cited by in Crossref: 86] [Cited by in F6Publishing: 46] [Article Influence: 12.3] [Reference Citation Analysis]
39 Kamimura K, Yokoo T, Abe H, Terai S. Gene Therapy for Liver Cancers: Current Status from Basic to Clinics. Cancers (Basel) 2019;11:E1865. [PMID: 31769427 DOI: 10.3390/cancers11121865] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
40 Kamitani N, Nomi T, Hokuto D, Yoshikawa T, Matsuo Y, Sho M. Primary undifferentiated carcinoma with osteoclast-like giant cells in liver and rapidly developing multiple metastases after curative hepatectomy: a case report. Int Cancer Conf J 2020;9:244-8. [PMID: 32904085 DOI: 10.1007/s13691-020-00436-0] [Reference Citation Analysis]
41 Kovács T, Máthé D, Fülöp A, Jemnitz K, Bátai-Konczos A, Veres Z, Török G, Veres DS, Horváth I, Szigeti K, Homolya L, Szijártó A. Functional shift with maintained regenerative potential following portal vein ligation. Sci Rep 2017;7:18065. [PMID: 29273725 DOI: 10.1038/s41598-017-18309-7] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
42 Abe H, Aida Y, Seki N, Sugita T, Tomita Y, Nagano T, Itagaki M, Sutoh S, Nagatsuma K, Itoh K, Matsuura T, Aizawa Y. Aldehyde dehydrogenase 2 polymorphism for development to hepatocellular carcinoma in East Asian alcoholic liver cirrhosis. J Gastroenterol Hepatol 2015;30:1376-83. [PMID: 25778454 DOI: 10.1111/jgh.12948] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
43 Zhu YY, Huang HY, Wu YL. Anticancer and apoptotic activities of oleanolic acid are mediated through cell cycle arrest and disruption of mitochondrial membrane potential in HepG2 human hepatocellular carcinoma cells. Mol Med Rep 2015;12:5012-8. [PMID: 26151733 DOI: 10.3892/mmr.2015.4033] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 7.0] [Reference Citation Analysis]
44 Scher N, Janoray G, Riet FG, Le Bayon AG, Debbi K, Lévy S, Louisot P, Garaud P, Chajon E, Barillot I, Salamé É, de Crevoisier R, Chapet S, Calais G. [Stereotactic body radiation therapy for hepatocellular carcinoma: Results from a retrospective multicentre study]. Cancer Radiother 2019;23:104-15. [PMID: 30952560 DOI: 10.1016/j.canrad.2018.07.138] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
45 Hiraki M, Kitahara K, Miyoshi A, Koga H, Nakamura H, Kubo H, Ikeda O, Yoshioka W, Nakashita S, Nishihara Y, Akashi M, Azama S, Kawaguchi Y, Mori D, Aishima S, Aibe H, Tanaka T, Sato S. A long-term survivor of undifferentiated carcinoma of the liver successfully treated with surgical treatments: A case report and literature review. Int J Surg Case Rep 2018;51:45-9. [PMID: 30142599 DOI: 10.1016/j.ijscr.2018.07.047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
46 Cristaudi A, Barizzi J, Rosso R, Varini M, Alerci M, Rubbia Brandt L, Majno P, Balzarotti Canger RC. Medullary-like hepatocellular carcinoma. J Surg Case Rep 2018;2018:rjy010. [PMID: 29435219 DOI: 10.1093/jscr/rjy010] [Reference Citation Analysis]
47 Wang ZG, He ZY, Chen YY, Gao H, Du XL. Incidence and survival outcomes of secondary liver cancer: a Surveillance Epidemiology and End Results database analysis. Transl Cancer Res 2021;10:1273-83. [PMID: 35116454 DOI: 10.21037/tcr-20-3319] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Roy S, Banerjee P, Ekser B, Bayless K, Zawieja D, Alpini G, Glaser SS, Chakraborty S. Targeting Lymphangiogenesis and Lymph Node Metastasis in Liver Cancer. Am J Pathol 2021;191:2052-63. [PMID: 34509441 DOI: 10.1016/j.ajpath.2021.08.011] [Reference Citation Analysis]
49 Burton MA, Gray BN, Klemp PF, Kelleher DK, Hardy N. Selective internal radiation therapy: distribution of radiation in the liver. Eur J Cancer Clin Oncol. 1989;25:1487-1491. [PMID: 2591440 DOI: 10.7861/clinmedicine.17-5-449] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
50 Lau EKC, Tsai B, Morrison H, Deftos M, Lin AY. Metachronous Hepatic Angiosarcoma Presenting as a Mimic of Recurrent Hepatocellular Carcinoma. J Gastrointest Cancer 2019;50:647-50. [PMID: 29623568 DOI: 10.1007/s12029-018-0094-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
51 Guenther E, Klein N, Mikus P, Botea F, Pautov M, Lugnani F, Macchioro M, Popescu I, Stehling MK, Rubinsky B. Toward a clinical real time tissue ablation technology: combining electroporation and electrolysis (E2). PeerJ 2020;8:e7985. [PMID: 31998549 DOI: 10.7717/peerj.7985] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Verhoeff K, Bacani J, Fung C, Canterbury LA. A Cholangioblastic Variant of Cholangiocarcinoma. ACG Case Rep J 2022;9:e00746. [PMID: 35187186 DOI: 10.14309/crj.0000000000000746] [Reference Citation Analysis]
53 Wang ZS, Guo WD, Wu LQ, Yi X, Geng C, Li YJ, Yao RY. Use of Cytokeratin-19 Concentration to Assess Early Recurrence and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma following Radical Resection in Patients with a Low Serum Alpha-Fetoprotein Concentration. PLoS One 2015;10:e0142727. [PMID: 26588210 DOI: 10.1371/journal.pone.0142727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
54 Ho JC, Nguyen L, Law JJ, Ware MJ, Keshishian V, Lara NC, Nguyen T, Curley SA, Corr SJ. Non-Invasive Radiofrequency Field Treatment to Produce Hepatic Hyperthermia: Efficacy and Safety in Swine. IEEE J Transl Eng Health Med 2017;5:1500109. [PMID: 28507824 DOI: 10.1109/JTEHM.2017.2672965] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
55 Kalantari K, Moniri M, Boroumand Moghaddam A, Abdul Rahim R, Bin Ariff A, Izadiyan Z, Mohamad R. A Review of the Biomedical Applications of Zerumbone and the Techniques for Its Extraction from Ginger Rhizomes. Molecules 2017;22:E1645. [PMID: 28974019 DOI: 10.3390/molecules22101645] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
56 Keller A, Bialecki P, Wilhelm TJ, Vetter MK. Diffuse reflectance spectroscopy of human liver tumor specimens - towards a tissue differentiating optical biopsy needle using light emitting diodes. Biomed Opt Express 2018;9:1069-81. [PMID: 29541504 DOI: 10.1364/BOE.9.001069] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
57 Kim YY, Kang TW, Cha DI, Min JH, Kim YK, Kim SH, Sinn DH, Won H, Kim S. Gadoxetic acid-enhanced MRI for differentiating hepatic sclerosing hemangioma from malignant tumor. Eur J Radiol 2021;135:109474. [PMID: 33352374 DOI: 10.1016/j.ejrad.2020.109474] [Reference Citation Analysis]
58 Yang XP, Zhou LX, Yang QJ, Liu L, Cai Y, Ma SL. Diagnostic and prognostic roles of serum vitronectin in hepatitis B-related hepatocellular carcinoma. Cancer Biomark 2016;17:271-9. [PMID: 27802203 DOI: 10.3233/CBM-160639] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
59 Yang D, Hanna DL, Usher J, LoCoco J, Chaudhari P, Lenz HJ, Setiawan VW, El-Khoueiry A. Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis. Cancer. 2014;120:3707-3716. [PMID: 25081299 DOI: 10.1002/cncr.28912] [Cited by in Crossref: 60] [Cited by in F6Publishing: 65] [Article Influence: 7.5] [Reference Citation Analysis]
60 Golubnitschaja O, Sridhar KC. Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes. Clin Exp Metastasis 2016;33:743-55. [PMID: 27541751 DOI: 10.1007/s10585-016-9816-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 21] [Article Influence: 4.3] [Reference Citation Analysis]
61 D'Emic N, Engelman A, Molitoris J, Hanlon A, Sharma NK, Moeslein FM, Chuong MD. Prognostic significance of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in patients treated with selective internal radiation therapy. J Gastrointest Oncol. 2016;7:269-277. [PMID: 27034796 DOI: 10.3978/j.issn.2078-6891.2015.108] [Cited by in F6Publishing: 11] [Reference Citation Analysis]
62 O’grady S, Lawless MW. Liver Cancer (Hepatocellular Carcinoma). Epigenetic Cancer Therapy. Elsevier; 2015. pp. 269-88. [DOI: 10.1016/b978-0-12-800206-3.00012-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
63 Tam HH, Al-nahhas A. Treatment of liver tumours with yttrium radioembolisation. Clin Transl Imaging 2014;2:165-82. [DOI: 10.1007/s40336-013-0046-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
64 Durot I, Wilson SR, Willmann JK. Contrast-enhanced ultrasound of malignant liver lesions. Abdom Radiol (NY) 2018;43:819-47. [PMID: 29094174 DOI: 10.1007/s00261-017-1360-8] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 9.8] [Reference Citation Analysis]
65 Peng J, Li JJ, Li J, Li HW, Xu GP, Jia RR, Zhang XN, Zhao Y. Could ADC values be a promising diagnostic criterion for differentiating malignant and benign hepatic lesions in Asian populations: A meta-analysis. Medicine (Baltimore) 2016;95:e5470. [PMID: 27902599 DOI: 10.1097/MD.0000000000005470] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
66 Ugurluer G, Mustafayev TZ, Gungor G, Atalar B, Abacioglu U, Sengoz M, Agaoglu F, Demir G, Ozyar E. Stereotactic MR-guided online adaptive radiation therapy (SMART) for the treatment of liver metastases in oligometastatic patients: initial clinical experience. Radiat Oncol J 2021;39:33-40. [PMID: 33794572 DOI: 10.3857/roj.2020.00976] [Reference Citation Analysis]
67 Alese OB, Kim S, Chen Z, Ramalingam SS, Owonikoko TK, El-Rayes BF. Analysis of liver-directed therapies in U.S. cancer patients. Curr Oncol 2015;22:e457-61. [PMID: 26715883 DOI: 10.3747/co.22.2819] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
68 Golubnitschaja O, Yeghiazaryan K, Stricker H, Trog D, Schild HH, Berliner L. Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours. BMC Cancer 2016;16:357. [PMID: 27277077 DOI: 10.1186/s12885-016-2382-2] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.8] [Reference Citation Analysis]
69 Castellví Q, Sánchez-velázquez P, Moll X, Berjano E, Andaluz A, Burdío F, Bijnens B, Ivorra A. Modeling liver electrical conductivity during hypertonic injection: Modeling Liver Electrical Conductivity during Hypertonic Injection. Int J Numer Meth Biomed Engng 2018;34:e2904. [DOI: 10.1002/cnm.2904] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
70 Sun D, Lu J, Hu C, Zhang Q, Wang X, Zhang Z, Hu S. Prognostic role of miR-760 in hepatocellular carcinoma. Oncol Lett. 2018;16:7239-7244. [PMID: 30546462 DOI: 10.3892/ol.2018.9546] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
71 Nakamura Y, Higaki T, Tatsugami F, Zhou J, Yu Z, Akino N, Ito Y, Iida M, Awai K. Deep Learning-based CT Image Reconstruction: Initial Evaluation Targeting Hypovascular Hepatic Metastases.Radiol Artif Intell. 2019;1:e180011. [PMID: 33937803 DOI: 10.1148/ryai.2019180011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
72 Liu N, Yang J, Huang Y, Chen B, Chen W, Li J. Vascular endothelial growth factor accelerates establishment of a model of hepatic metastasis in Walker-256 tumor-bearing rats. Am J Med Sci 2015;349:234-9. [PMID: 25310512 DOI: 10.1097/MAJ.0000000000000359] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
73 Kuei A, Saab S, Cho SK, Kee ST, Lee EW. Effects of Yttrium-90 selective internal radiation therapy on non-conventional liver tumors. World J Gastroenterol 2015; 21(27): 8271-8283 [PMID: 26217079 DOI: 10.3748/wjg.v21.i27.8271] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
74 Lam P, Obirieze A, Ortega G, Nwokeabia I, Onyewu S, Purnell S, Samimi M, Weeks C, Lee E, Shokrani B, Frederick W, Callender C, Wilson L. Characterization of Hepatitis B and C Among Liver Transplant Recipients With Hepatocellular Carcinoma: An Analysis of the Nationwide Inpatient Sample Database. Transplantation Proceedings 2016;48:123-7. [DOI: 10.1016/j.transproceed.2015.12.008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
75 Abrantes AM, Pires AS, Monteiro L, Teixo R, Neves AR, Tavares NT, Marques IA, Botelho MF. Tumour functional imaging by PET. Biochim Biophys Acta Mol Basis Dis 2020;1866:165717. [PMID: 32035103 DOI: 10.1016/j.bbadis.2020.165717] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
76 Geramizadeh B, Abdi M. The Origin of Liver Metastatic Adenocarcinomas, a Single Center Experience from the South of Iran. Hepat Mon 2019;19. [DOI: 10.5812/hepatmon.91211] [Reference Citation Analysis]
77 Pant K, Venugopal SK. Circulating microRNAs: Possible role as non-invasive diagnostic biomarkers in liver disease. Clinics and Research in Hepatology and Gastroenterology 2017;41:370-7. [DOI: 10.1016/j.clinre.2016.11.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
78 Louvet A, Duconseille AC. Feasibility for detecting liver metastases in dogs using gadobenate dimeglumine-enhanced magnetic resonance imaging. Vet Radiol Ultrasound 2015;56:286-95. [PMID: 25529873 DOI: 10.1111/vru.12237] [Cited by in Crossref: 8] [Article Influence: 1.0] [Reference Citation Analysis]
79 Nasir A, Manivel JC, Yousaf H, Albrecht JH, Dykoski R, Mesa H. Markedly Increased Rate of Primary Liver Malignancies at Autopsy in Male US Veterans. Clin Gastroenterol Hepatol 2017;15:316-8. [PMID: 27574757 DOI: 10.1016/j.cgh.2016.08.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
80 Danish Mund M, Alam S, Hassan Khan U, Tahir U, Saad Zubair M, Younas T, Mustafa B. Phytochemicals as Complementary and Alternative Therapeutic Formulations with Potential pro-Apoptotic Effects on Various Cancerous Cell Lines: A Literature Survey. Foc Sci 2016;2:1-10. [DOI: 10.20286/focsci-020220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
81 Park J, Jeong D, Song M, Kim B. Recent Advances in Anti-Metastatic Approaches of Herbal Medicines in 5 Major Cancers: From Traditional Medicine to Modern Drug Discovery. Antioxidants (Basel) 2021;10:527. [PMID: 33801741 DOI: 10.3390/antiox10040527] [Reference Citation Analysis]
82 Vorontsov E, Abi-jaoudeh N, Kadoury S. Metastatic Liver Tumor Segmentation Using Texture-Based Omni-Directional Deformable Surface Models. In: Yoshida H, Näppi JJ, Saini S, editors. Abdominal Imaging. Computational and Clinical Applications. Cham: Springer International Publishing; 2014. pp. 74-83. [DOI: 10.1007/978-3-319-13692-9_7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.1] [Reference Citation Analysis]
83 Adcock CS, Florez E, Zand KA, Patel A, Howard CM, Fatemi A. Assessment of Treatment Response Following Yttrium-90 Transarterial Radioembolization of Liver Malignancies. Cureus 2018;10:e2895. [PMID: 30175001 DOI: 10.7759/cureus.2895] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
84 Habs M, Binder K, Krauss S, Müller K, Ernst B, Valentini L, Koller M. A Balanced Risk-Benefit Analysis to Determine Human Risks Associated with Pyrrolizidine Alkaloids (PA)-The Case of Tea and Herbal Infusions. Nutrients 2017;9:E717. [PMID: 28686224 DOI: 10.3390/nu9070717] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
85 [DOI: 10.1101/554600] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
86 Al-Shakarchi W, Alsuraifi A, Abed M, Abdullah M, Richardson A, Curtis A, Hoskins C. Combined Effect of Anticancer Agents and Cytochrome C Decorated Hybrid Nanoparticles for Liver Cancer Therapy. Pharmaceutics 2018;10:E48. [PMID: 29649145 DOI: 10.3390/pharmaceutics10020048] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
87 Rosenberg SA, Henke LE, Shaverdian N, Mittauer K, Wojcieszynski AP, Hullett CR, Kamrava M, Lamb J, Cao M, Green OL, Kashani R, Paliwal B, Bayouth J, Harari PM, Olsen JR, Lee P, Parikh PJ, Bassetti M. A Multi-Institutional Experience of MR-Guided Liver Stereotactic Body Radiation Therapy. Adv Radiat Oncol 2019;4:142-9. [PMID: 30706022 DOI: 10.1016/j.adro.2018.08.005] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
88 Mima K, Baba H. The gut microbiome, antitumor immunity, and liver cancer. Hepatobiliary Surg Nutr 2019;8:67-8. [PMID: 30881970 DOI: 10.21037/hbsn.2018.11.09] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Desai A, Sandhu S, Lai JP, Sandhu DS. Hepatocellular carcinoma in non-cirrhotic liver: A comprehensive review. World J Hepatol 2019; 11(1): 1-18 [PMID: 30705715 DOI: 10.4254/wjh.v11.i1.1] [Cited by in Crossref: 77] [Cited by in F6Publishing: 59] [Article Influence: 25.7] [Reference Citation Analysis]
90 Sufleţel RT, Melincovici CS, Gheban BA, Toader Z, Mihu CM. Hepatic stellate cells - from past till present: morphology, human markers, human cell lines, behavior in normal and liver pathology. Rom J Morphol Embryol 2020;61:615-42. [PMID: 33817704 DOI: 10.47162/RJME.61.3.01] [Reference Citation Analysis]
91 Radjenović B, Sabo M, Šoltes L, Prnova M, Čičak P, Radmilović-Radjenović M. On Efficacy of Microwave Ablation in the Thermal Treatment of an Early-Stage Hepatocellular Carcinoma. Cancers (Basel) 2021;13:5784. [PMID: 34830937 DOI: 10.3390/cancers13225784] [Reference Citation Analysis]
92 Shiraha H, Iwamuro M, Okada H. Hepatic Stellate Cells in Liver Tumor. Adv Exp Med Biol 2020;1234:43-56. [PMID: 32040854 DOI: 10.1007/978-3-030-37184-5_4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
93 Barry AE, Baldeosingh R, Lamm R, Patel K, Zhang K, Dominguez DA, Kirton KJ, Shah AP, Dang H. Hepatic Stellate Cells and Hepatocarcinogenesis. Front Cell Dev Biol 2020;8:709. [PMID: 32850829 DOI: 10.3389/fcell.2020.00709] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 8.5] [Reference Citation Analysis]
94 Cwinn M, Walsh G, Rahman SH, Molinari M. The Geography of Primary Hepatic Neoplasms Treatments in Canada: Changes in Latitudes and Changes in Attitudes. Can J Gastroenterol Hepatol 2017;2017:9365657. [PMID: 28815170 DOI: 10.1155/2017/9365657] [Reference Citation Analysis]
95 Sharifi F, Yesil-celiktas O, Kazan A, Maharjan S, Saghazadeh S, Firoozbakhsh K, Firoozabadi B, Zhang YS. A hepatocellular carcinoma–bone metastasis-on-a-chip model for studying thymoquinone-loaded anticancer nanoparticles. Bio-des Manuf 2020;3:189-202. [DOI: 10.1007/s42242-020-00074-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
96 Ivashchenko OV, Rijkhorst EJ, Ter Beek LC, Hoetjes NJ, Pouw B, Nijkamp J, Kuhlmann KFD, Ruers TJM. A workflow for automated segmentation of the liver surface, hepatic vasculature and biliary tree anatomy from multiphase MR images. Magn Reson Imaging 2020;68:53-65. [PMID: 31935445 DOI: 10.1016/j.mri.2019.12.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
97 Aubry JF, Pauly KB, Moonen C, Haar GT, Ries M, Salomir R, Sokka S, Sekins KM, Shapira Y, Ye F, Huff-Simonin H, Eames M, Hananel A, Kassell N, Napoli A, Hwang JH, Wu F, Zhang L, Melzer A, Kim YS, Gedroyc WM. The road to clinical use of high-intensity focused ultrasound for liver cancer: technical and clinical consensus. J Ther Ultrasound 2013;1:13. [PMID: 25512859 DOI: 10.1186/2050-5736-1-13] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 6.7] [Reference Citation Analysis]
98 Golubnitschaja O, Polivka J Jr, Yeghiazaryan K, Berliner L. Liquid biopsy and multiparametric analysis in management of liver malignancies: new concepts of the patient stratification and prognostic approach. EPMA J 2018;9:271-85. [PMID: 30174763 DOI: 10.1007/s13167-018-0146-6] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]